Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|August 16, 2008
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptorMariangela Figini, Franck Martin, Renata Ferri, et al.
Nanoscale|December 16, 2014
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivoAlessandra Quarta, Davide Bernareggi, Fabio Benigni, et al.
Oncotarget|March 7, 2015
A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classificationMatteo Dugo, Gabriella Nicolini, Gabrina Tragni, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 10, 2023
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalitiesDeborah Lenoci, Carlo Resteghini, Mara S Serafini, et al.
Oncotarget|January 5, 2017
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imagingBarbara Frigerio, Gerben Franssen, Elena Luison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinomaDelia Mezzanzanica, Emanuela Balladore, Fabio Turatti, et al.
Plos One|October 3, 2012
Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissuesMaurizio Callari, Matteo Dugo, Valeria Musella, et al.
Oncotarget|March 23, 2015
Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinomaAnna Granata, Roberta Nicoletti, Paola Perego, et al.
Oncotarget|January 17, 2012
Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patientsMarina Bagnoli, Loris De Cecco, Anna Granata, et al.
The Journal of Investigative Dermatology|July 29, 2011
Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinaseMarialuisa Sensi, Mara Catani, Giancarlo Castellano, et al.
Pageof 12